Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Cash position

<< Previous

Bullboard Posts

Next >>

Post by Yajneon Nov 30, 2022 10:06pm

386 Views

Post# 35141786

Cash position

Has anybody closely reviewed the cash position? Please correct me if I'm wrong but I think proceeds of the initial $2.5 mil pp are included in Sept.30 cash balance, and then another $250k from subsequent pp after Sept 30. I have also estimated cash burn at just over $400k/mo, so about 6.5 mo of 'runway' as of Sept.30. Is that consistent with how others see cash position?

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project